January 1, 2013 Understanding Placebo Responses in Alzheimer’s Disease Clinical Trials from the Literature Meta-Data and CAMD Database
December 23, 2012 Research and standardization in Alzheimer’s trials: reaching international consensus
December 7, 2012 The National Multiple Sclerosis Society and Critical Path Institute Create the Multiple Sclerosis Outcome Assessments Consortium
November 29, 2012 C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we
November 16, 2012 Assessment of the Most Relevant Symptoms Reported By Patients with Major Depressive Disorder
November 4, 2012 How do Patients Describe Their Depression? – Incorporating the Patient’s Voice into Instrument Development
November 4, 2012 Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses from Semi-Structured Qualitative Interviews in Patients with Major Depressive Disorder
November 3, 2012 Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis (RA): The Role of the Patient-Reported Outcome Consortium’s RA Working Group
